CareSpan Health, Inc.
CSPN.V
TSX
| Weiss Ratings | CSPN.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | CSPN.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CSPN.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -1.65 | |||
| Price History | CSPN.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -20.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | -33.33% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -60.00% | |||
| 2-Year Total Return | -75.00% | |||
| 3-Year Total Return | -94.52% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -66.67% | |||
| 52-Week Low % Change | 33.33% | |||
| Price | CSPN.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.06 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Jul 24, 2024 | |||
| 52-Week High Price (Date) | Mar 07, 2024 | |||
| Valuation | CSPN.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 660.83K | |||
| Enterprise Value | 1.96M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -71.72% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.56 | |||
| Price/Book (Q) | -0.38 | |||
| Enterprise Value/Revenue (TTM) | 1.15 | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | -3.61 | |||
| Enterprise Value/EBIT | -2.86 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CSPN.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 47.62M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CSPN.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 303 800 8296 | |||
| Address | 105 East, 34th Street New York, NY 10016 | |||
| Website | www.carespanhealth.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | CSPN.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -40.37% | |||
| Profit Margin | -19.26% | |||
| Management Effectiveness | CSPN.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -130.94% | |||
| Return on Equity | -- | |||
| Income Statement | CSPN.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.71M | |||
| Total Revenue (TTM) | 1.71M | |||
| Revenue Per Share | $0.04 | |||
| Gross Profit (TTM) | -144.20K | |||
| EBITDA (TTM) | -545.80K | |||
| EBIT (TTM) | -689.80K | |||
| Net Income (TTM) | -329.10K | |||
| Net Income Avl. to Common (TTM) | -329.10K | |||
| Total Revenue Growth (Q YOY) | -70.01% | |||
| Earnings Growth (Q YOY) | 78.01% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 77.92% | |||
| Balance Sheet | CSPN.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 17.50K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 338.20K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -2.53M | |||
| Current Ratio (Q) | 0.118 | |||
| Book Value Per Share (Q) | -$0.05 | |||
| Total Assets (Q) | 338.20K | |||
| Total Current Liabilities (Q) | 2.87M | |||
| Total Debt (Q) | 1.40M | |||
| Total Liabilities (Q) | 2.87M | |||
| Total Common Equity (Q) | -2.53M | |||
| Cash Flow | CSPN.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 381.90K | |||
| Net Change in Cash (TTM) | -26.80K | |||
| Levered Free Cash Flow (TTM) | -538.10K | |||
| Cash from Operations (TTM) | -409.70K | |||
